BiomX Inc.
PHGE · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6 | $5 | $5 | $12 |
| G&A Expenses | $0 | $2 | $3 | $2 |
| SG&A Expenses | $2 | $2 | $3 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $4 |
| Other Operating Expenses | $0 | -$0 | $0 | -$34 |
| Operating Expenses | $9 | $7 | $8 | -$17 |
| Operating Income | -$9 | -$7 | -$8 | $17 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$1 | $1 | $0 | -$31 |
| Pre-Tax Income | -$9 | -$6 | -$8 | -$15 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$6 | -$8 | -$15 |
| % Margin | – | – | – | – |
| EPS | -0.051 | -3.61 | -6.27 | -3.99 |
| % Growth | 98.6% | 42.4% | -57.1% | – |
| EPS Diluted | 5.51 | -3.61 | -6.27 | -15.2 |
| Weighted Avg Shares Out | 2 | 2 | 1 | 4 |
| Weighted Avg Shares Out Dil | 1,653 | 2 | 1,216 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $1 |
| EBITDA | -$9 | -$6 | -$7 | -$8 |
| % Margin | – | – | – | – |